Today: 26 January 2026
Subscribe
Browse Category

Financial Analysis News 12 December 2025 - 13 December 2025

Big Tech Stocks Sink as AI Payoff Fears Hit Broadcom and Oracle; Nvidia’s China Signal Adds a Twist (Dec. 12, 2025)

Big Tech Stocks Sink as AI Payoff Fears Hit Broadcom and Oracle; Nvidia’s China Signal Adds a Twist (Dec. 12, 2025)

Big Tech stocks slid on Dec. 12, 2025 as Broadcom and Oracle reignited “AI bubble” worries, pushing chip leaders lower while investors refocus on margins, capex, and cash flow. NEW YORK (Updated Dec. 12, 2025, 6:00 p.m. ET) — Big Tech stocks ended the week under pressure Friday as a renewed “AI payoff” debate rippled through the market, dragging down semiconductors…
13 December 2025
····
Top Stock Losers Today (Dec. 12, 2025): SanDisk, Broadcom and Oracle Sink as AI Trade Takes a Hit After the Close

Top Stock Losers Today (Dec. 12, 2025): SanDisk, Broadcom and Oracle Sink as AI Trade Takes a Hit After the Close

U.S. stocks fell Friday as investors rotated out of AI and semiconductors. SanDisk and Broadcom led declines, while Oracle extended its slide. What’s next. NEW YORK — Friday, Dec. 12, 2025 (updated for 6:00 PM EST) — Wall Street finished the week with a sharp, tech-led pullback, and the day’s biggest losers read like a roll call of the AI boom.…
13 December 2025
····
GE Vernova (GEV) Stock After Hours on Dec. 12, 2025: Why Shares Slid After the Investor-Day Spike—and What to Watch Next

GE Vernova (GEV) Stock After Hours on Dec. 12, 2025: Why Shares Slid After the Investor-Day Spike—and What to Watch Next

(SEO): GE Vernova (NYSE: GEV) fell Friday and eased after hours. Here’s the latest price action, the key Dec. 12 news, analyst calls, and what matters next. GE Vernova Inc. (NYSE: GEV) ended Friday, December 12, 2025, under pressure after an explosive midweek run-up. Shares closed at $671.71, down 4.61% on the day after trading between $698.94 and $656.37. StockAnalysis…
12 December 2025
····
lululemon (LULU) stock after hours Dec. 12, 2025: CEO succession rally, raised guidance, and what to know before the next open

lululemon (LULU) stock after hours Dec. 12, 2025: CEO succession rally, raised guidance, and what to know before the next open

lululemon athletica inc. (NASDAQ: LULU) capped a volatile week with a sharp post-earnings re-rating—then held onto most of those gains after Friday’s closing bell. The move is being driven by a rare combination of catalysts: a CEO transition announcement, an earnings beat, a raised full‑year outlook, and a fresh wave of Wall Street price‑target changes and “reset” narratives published on…
12 December 2025
···
Rigetti Computing (RGTI) Stock News on Dec. 12, 2025: Mizuho’s $50 Target, Fresh Catalysts, and the Big Risks Behind the Quantum Rally

Rigetti Computing (RGTI) Stock News on Dec. 12, 2025: Mizuho’s $50 Target, Fresh Catalysts, and the Big Risks Behind the Quantum Rally

(SEO): Rigetti Computing (NASDAQ: RGTI) is in focus on Dec. 12, 2025 after a bullish Mizuho initiation. Here’s the latest news, forecasts, and what to watch next. Rigetti Computing, Inc. (NASDAQ: RGTI) is back in the spotlight on December 12, 2025, as Wall Street’s appetite for “pure-play” quantum computing exposure collides with a sector reality: massive long-term potential, inconsistent near-term…
12 December 2025
····
Ares Capital (ARCC) Stock News Today (Dec. 12, 2025): Dividend Date, $1B CLO Financing, and Wall Street Forecasts

Ares Capital (ARCC) Stock News Today (Dec. 12, 2025): Dividend Date, $1B CLO Financing, and Wall Street Forecasts

Ares Capital Corporation (NASDAQ: ARCC ) is back in the spotlight on December 12, 2025 , as income investors weigh a near-term dividend catalyst against new balance-sheet activity and a steady drumbeat of analyst coverage. As of today, ARCC was trading around $20.90 per share, with intraday pricing hovering in a tight range—typical for a large, diversified business development company…
12 December 2025
····
Lemonade Stock (LMND) News Today: Tesla Car Connection, Insider Sales, and Analyst Targets in Focus on Dec. 12, 2025

Lemonade Stock (LMND) News Today: Tesla Car Connection, Insider Sales, and Analyst Targets in Focus on Dec. 12, 2025

NEW YORK — Dec. 12, 2025 — Lemonade, Inc. (NYSE: LMND ) is closing out the week as one of the most closely watched names in the insurtech space, with the stock trading near 52‑week highs after a sharp run-up and a burst of fresh headlines. The latest narrative combines three themes investors typically react to quickly: product momentum ,…
12 December 2025
···
Nebius Group (NBIS) Stock Drops on AI Spending Jitters: Latest News, Forecasts, and What Investors Are Watching on Dec. 12, 2025

Nebius Group (NBIS) Stock Drops on AI Spending Jitters: Latest News, Forecasts, and What Investors Are Watching on Dec. 12, 2025

Updated: Friday, December 12, 2025 Nebius Group N.V. (NASDAQ: NBIS) is having another volatile session—one that captures the push-and-pull investors have been feeling across “AI infrastructure” stocks: confidence in long-term demand, paired with fresh anxiety over the cost of building it. As of 17:27 UTC (12:27 p.m. ET) on Dec. 12, NBIS traded at $89.88, down 4.67% on the day,…
12 December 2025
····
IREN Limited Stock (NASDAQ: IREN) News and Forecasts on Dec. 12, 2025: Microsoft AI Deal, $2.3B Convertibles, Analyst Price Targets

IREN Limited Stock (NASDAQ: IREN) News and Forecasts on Dec. 12, 2025: Microsoft AI Deal, $2.3B Convertibles, Analyst Price Targets

IREN Limited (NASDAQ: IREN) shares were under pressure on Friday, December 12, 2025, as investors continued to digest the company’s early-December financing package and what it means for dilution, debt costs, and the pace of its AI data-center buildout. Midday pricing data showed IREN trading around the low-$40s and down mid-to-high single digits on the session. StockAnalysis The bigger story…
12 December 2025
···
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Here are the biggest US stock market gainers at midday on Dec. 12, 2025—plus what’s driving the moves, from cannabis policy headlines to earnings reports and SEC filings.  StockAnalysis At 12:30 p.m. ET on Friday, December 12, 2025, the US stock market is showing a familiar split screen: broad indexes are lower, led by weakness in tech and semiconductors, while a handful…
12 December 2025
····
Broadcom Earnings: AVGO Forecasts $19.1B Revenue as AI Chip Demand Surges—But Margin Concerns Slam the Stock

Broadcom Earnings: AVGO Forecasts $19.1B Revenue as AI Chip Demand Surges—But Margin Concerns Slam the Stock

Broadcom beat Q4 estimates, lifted its dividend, and guided Q1 revenue to $19.1B as AI chip sales accelerate—yet investors sold off on margin and AI payback concerns. Dec. 12, 2025 — Broadcom’s latest earnings were supposed to be a clear win for the AI ​​infrastructure trade: record quarterly revenue, a stronger-than-expected outlook, and a fast-growing pipeline of custom AI chips…
12 December 2025
····
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025)

Geron Corporation (NASDAQ: GERN) stock is back in focus on December 12, 2025, as investors digest a sweeping restructuring tied to the company’s commercial push for RYTELO (imetelstat) and its longer-term clinical ambitions. The headlines have been loud—one-third of the workforce is set to be cut, analysts are re-checking their models, and the market is weighing a familiar biotech question:…
12 December 2025
····
1 … 142 143 144 145 146 … 237

Stock Market Today

  • Hims & Hers Health (HIMS) Shares Drop Amid Valuation Debate After Volatile Trading
    January 26, 2026, 5:56 AM EST. Hims & Hers Health (NYSE:HIMS) shares fell 14% over the past month, extending a 37% slide over three months, despite a nearly 3x total return over three years. The stock closed at $29.62, trading well below a bullish fair value estimate of $173.02, based on expectations for strong revenue growth, rising profit margins, and high future earnings multiples typical of growth leaders. However, the current price-to-earnings (P/E) ratio of 50.4 times eclipses the healthcare sector average (23.4x) and peers (33.6x), raising concerns over valuation risk if growth forecasts falter. Key risks include telehealth demand shifts and regulatory changes affecting weight loss products. Investors face a trade-off: pay a premium for growth potential or reassess assumptions amid recent volatility and mixed momentum signals.
Go toTop